4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0000899243-16-025724
Chief Financial Officer bought 16,000 shares at an average $3.12 ($49,862)
From the SEC's structured data for this filing
Trades in this filing
Allen Patricia L · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-07-25 | Purchase : show line 1 in the form | +7,800 | $3.08 | $24,032 | 11,593 | D |
| 2016-07-26 | Purchase : show line 2 in the form | +8,200 | $3.15 | $25,830 | 19,793 | D |
| Open-market purchases · 16,000 sh · avg $3.12 · $49,862 | ||||||
Loading xslF345X03/doc4.xml…